CCI vs IRD · P/E 40, rev $6.57B vs rev $11.0M
Crown Castle (CCI) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CCI and IRD stock pages for the full models.
Not investment advice.